Joseph K. Belanoff

2017

In 2017, Joseph K. Belanoff earned a total compensation of $4.3M as Chief Executive Officer and President at Corcept Therapeutics, a 78% increase compared to previous year.

Compensation breakdown

Bonus$702,000
Option Awards$2,922,119
Salary$647,333
Total$4,271,452

Belanoff received $2.9M in option awards, accounting for 68% of the total pay in 2017.

Belanoff also received $702K in bonus and $647.3K in salary.

Rankings

In 2017, Joseph K. Belanoff's compensation ranked 2,350th out of 14,666 executives tracked by ExecPay. In other words, Belanoff earned more than 84.0% of executives.

ClassificationRankingPercentile
All
2,350
out of 14,666
84th
Division
Manufacturing
824
out of 5,768
86th
Major group
Chemicals And Allied Products
217
out of 2,074
90th
Industry group
Drugs
166
out of 1,730
90th
Industry
Pharmaceutical Preparations
131
out of 1,329
90th
Source: SEC filing on April 24, 2018.

Belanoff's colleagues

We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2017.

2017

Sean Maduck

Corcept Therapeutics

Senior Vice President, Commercial

2017

Charles Robb

Corcept Therapeutics

Chief Financial Officer

2017

G Robb

Corcept Therapeutics

Chief Financial Officer

2017

Robert Fishman

Corcept Therapeutics

Chief Medical Officer

News

In-depth

You may also like